Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/104743
Title: | Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies | Authors: | Serrenho, Inês Rosado, Miguel Dinis, Alexandra M Cardoso, Carla Grãos, Mário Manadas, Bruno Baltazar, Graça Maria Fernandes |
Keywords: | hypoxic-ischemic encephalopathy; stem cell therapy; umbilical cord blood cells; umbilical cord tissue; mesenchymal stem/stromal cells; therapeutic hypothermia | Issue Date: | 19-Mar-2021 | Publisher: | MDPI AG | Project: | POCI-01–0145-FEDER-029311 (ref.: PTDC/BTM-TEC/29311/2017) UIDB/04539/2020 POCI-01– 0145-FEDER-016428 (ref.: SAICTPAC/0010/2015) POCI-01–0145-FEDER-016795 (ref.: PTDC/NEUSCC/ 7051/2014) POCI-01–0145-FEDER-029516 (PTDC/MED-NEU/29516/2017) RescueCord POCI- 01–0247-FEDER-045311 UIDB/00709/2020 |
Serial title, monograph or event: | International Journal of Molecular Sciences | Volume: | 22 | Issue: | 6 | Abstract: | Neonatal hypoxic-ischemic encephalopathy (HIE) is an important cause of mortality and morbidity in the perinatal period. This condition results from a period of ischemia and hypoxia to the brain of neonates, leading to several disorders that profoundly affect the daily life of patients and their families. Currently, therapeutic hypothermia (TH) is the standard of care in developing countries; however, TH is not always effective, especially in severe cases of HIE. Addressing this concern, several preclinical studies assessed the potential of stem cell therapy (SCT) for HIE. With this systematic review, we gathered information included in 58 preclinical studies from the last decade, focusing on the ones using stem cells isolated from the umbilical cord blood, umbilical cord tissue, placenta, and bone marrow. Outstandingly, about 80% of these studies reported a significant improvement of cognitive and/or sensorimotor function, as well as decreased brain damage. These results show the potential of SCT for HIE and the possibility of this therapy, in combination with TH, becoming the next therapeutic approach for HIE. Nonetheless, few preclinical studies assessed the combination of TH and SCT for HIE, and the existent studies show some contradictory results, revealing the need to further explore this line of research. | URI: | https://hdl.handle.net/10316/104743 | ISSN: | 1422-0067 | DOI: | 10.3390/ijms22063142 | Rights: | openAccess |
Appears in Collections: | I&D CNC - Artigos em Revistas Internacionais IIIUC - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Stem-cell-therapy-for-neonatal-hypoxicischemic-encephalopathy-A-systematic-review-of-preclinical-studiesInternational-Journal-of-Molecular-Sciences.pdf | 2.48 MB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
33
checked on Apr 2, 2024
Page view(s)
77
checked on Aug 28, 2024
Download(s)
60
checked on Aug 28, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License